PAD regimen

{
  "id": "MLC-T-ONC-006250",
  "term": "PAD regimen",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An abbreviation for a chemotherapy combination used to treat multiple myeloma. It includes the drugs bortezomib, doxorubicin (Adriamycin), and dexamethasone. Also called PAD.",
    "A chemotherapy regimen containing bortezomib, doxorubicin and dexamethasone regimen used in the treatment of plasma cell myeloma."
  ],
  "abbreviation": "PAD",
  "synonyms": [
    "PAD",
    "bortezomib-doxorubicin-dexamethasone regimen",
    "bortezomib/doxorubicin/dexamethasone regimen",
    "Velcade/adriamycin/dexamethasone regimen",
    "bortezomib/ dexamethasone/doxorubicin",
    "PS-341/Adriamycin/dexamethasone regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/pad-regimen/"
}